BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28815294)

  • 1. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
    Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
    Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth.
    Lai KC; Hsu SC; Yang JS; Yu CC; Lein JC; Chung JG
    J Cell Mol Med; 2015 Feb; 19(2):474-84. PubMed ID: 25403643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
    Li Y; Zhang J; Zhang L; Si M; Yin H; Li J
    Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway.
    Xu X; Mao W; Chen Q; Zhuang Q; Wang L; Dai J; Wang H; Huang Z
    PLoS One; 2014; 9(9):e107463. PubMed ID: 25232946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions.
    Lai KC; Hsu SC; Kuo CL; Yang JS; Ma CY; Lu HF; Tang NY; Hsia TC; Ho HC; Chung JG
    Environ Toxicol; 2013 Sep; 28(9):479-88. PubMed ID: 21695758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.
    He P; Wang Z; Sheng B; Xu Y; Feng S; Huang Y; Gong F; Tang L; Xie L
    Histol Histopathol; 2020 Dec; 35(12):1511-1520. PubMed ID: 33372687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
    Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
    Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway.
    Li X; Meng Y; Xie C; Zhu J; Wang X; Li Y; Geng S; Wu J; Zhong C; Li M
    J Cell Biochem; 2018 May; 119(5):4134-4141. PubMed ID: 29243835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
    Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV
    Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin modulates chronic tobacco smoke exposure-induced acquisition of pulmonary cancer stem cell properties and diallyl trisulfide intervention.
    Wang J; Chen J; Jiang Y; Shi Y; Zhu J; Xie C; Geng S; Wu J; Zhang Q; Wang X; Meng Y; Li Y; Chen Y; Cao W; Wang X; Zhong C; Li X
    Toxicol Lett; 2018 Jul; 291():70-76. PubMed ID: 29626521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
    Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
    Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
    Ni H; Ji D; Li J; Zhao Z; Zuo J
    Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
    Zhang D; Guo S; Wang H; Hu Y
    Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
    Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.